A key finding of this study was the significant suppression of the KEAP1-NFE2L2 pathway identified through QIAGEN IPA, with suppression observed in both IH and SH groups compared to the control group and notably stronger suppression in the IH group. The gene discussed is NFE2L2; the disease is isolated hemihyperplasia.